Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.
Terrestrial Bio has raised $50.0M in total funding. The most recent round was Series C. The last funding was announced in March 2026.
Terrestrial Bio's investors include RA Capital Management, Bill & Melinda Gates Foundation, National Science Foundation, Engine Ventures, Verizon.
Terrestrial Bio is headquartered in Cambridge, United States.
Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.
Terrestrial Bio is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Terrestrial Bio — Funding & Investors." VCBacked, March 26, 2026, https://www.vcbacked.co/company/terrestrial-bio. Accessed October 6, 2026.
VCBacked. (2026). Terrestrial Bio — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/terrestrial-bio
{{cite web |title=Terrestrial Bio — Funding & Investors |url=https://www.vcbacked.co/company/terrestrial-bio |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated